323 related articles for article (PubMed ID: 28662703)
1. The diagnosis of a metastatic breast tumor from ovarian cancer by the succession of a p53 mutation: a case report.
Mori R; Futamura M; Morimitsu K; Saigo C; Miyazaki T; Yoshida K
World J Surg Oncol; 2017 Jun; 15(1):117. PubMed ID: 28662703
[TBL] [Abstract][Full Text] [Related]
2. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
[TBL] [Abstract][Full Text] [Related]
3. [Metastases to the breast from non-mammary malignancies: a clinicopathologic study of 28 cases].
Zhou S; Yu B; Cheng Y; Xu X; Shui R; Bi R; Lu H; Tu X; Yang W
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):231-5. PubMed ID: 24915812
[TBL] [Abstract][Full Text] [Related]
4. [Multiple primary malignancies in BRCA1 mutation carriers--two clinical cases].
Badora A; Kaleta B; Nowara E; Sikora-Jopek M; Budryk M; Smok-Ragankiewicz A
Ginekol Pol; 2013 Oct; 84(10):892-6. PubMed ID: 24273914
[TBL] [Abstract][Full Text] [Related]
5. Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report.
Maeshima Y; Osako T; Morizono H; Yunokawa M; Miyagi Y; Kikuchi M; Ueno T; Ohno S; Akiyama F
J Med Case Rep; 2021 Feb; 15(1):78. PubMed ID: 33593410
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer metastasis to the breast 18 years after the initial diagnosis: A case report.
Wang Z; Zhao D; Liu R; Zheng B
Medicine (Baltimore); 2019 Oct; 98(43):e17577. PubMed ID: 31651861
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of primary versus metastatic ovarian adenocarcinoma using p53 gene mutation analysis.
Yamano T; Morii E; Arai I; Takada T; Kubota K; Sato M; Inoue T; Okada Y; Hara T; Aozasa K
Int J Clin Oncol; 2010 Dec; 15(6):621-5. PubMed ID: 20514505
[TBL] [Abstract][Full Text] [Related]
8. Atypical sigmoid metastasis from a high-grade mixed adenocarcinoma of the ovary.
Zighelboim I; Broaddus R; Ramirez PT
Gynecol Oncol; 2004 Sep; 94(3):850-3. PubMed ID: 15350388
[TBL] [Abstract][Full Text] [Related]
9. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
10. Breast metastasis 56 months before the diagnosis of primary ovarian cancer: a case study.
Schneuber SE; Scholz HS; Regitnig P; Petru E; Winter R
Anticancer Res; 2008; 28(5B):3047-50. PubMed ID: 19031954
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous bilateral breast carcinomas: a category with frequent coexpression of HER-2 and ER-alpha, high Ki-67 and bcl-2, and low p53.
Bassarova AV; Nesland JM; Sedloev T; Lilleby W; Hristova SL; Trifonov DY; Torlakovic E
Int J Surg Pathol; 2005 Jul; 13(3):239-46. PubMed ID: 16086078
[TBL] [Abstract][Full Text] [Related]
12. Metastatic ovarian serous carcinoma presenting as inflammatory breast cancer: a case report.
Gingell D; Samuel A; Haynik D; McBee W; Kelley J; Zorn K; Bhargava R
Int J Gynecol Pathol; 2010 May; 29(3):243-7. PubMed ID: 20407323
[TBL] [Abstract][Full Text] [Related]
13. GATA3 expression in clinically useful groups of breast carcinoma: a comparison with GCDFP15 and mammaglobin for identifying paired primary and metastatic tumors.
Yang Y; Lu S; Zeng W; Xie S; Xiao S
Ann Diagn Pathol; 2017 Feb; 26():1-5. PubMed ID: 28038704
[TBL] [Abstract][Full Text] [Related]
14. A diagnostic dilemma following risk-reducing surgery for BRCA1 mutation - a case report of primary papillary serous carcinoma presenting as sigmoid cancer.
Chand M; Moore PJ; Clarke AD; Nash GF; Hickisk T
World J Surg Oncol; 2007 Sep; 5():102. PubMed ID: 17850658
[TBL] [Abstract][Full Text] [Related]
15. [Primary ovarian malignant mixed mesodermal tumor (MMMT) as a second primary tumor in a patient with invasive breast carcinoma--case report].
Sentija K; Bolanca IK; Simon SK; Kukura V; Skrtić A; Gasparov S
Acta Med Croatica; 2011 Sep; 65 Suppl 1():229-34. PubMed ID: 23126058
[TBL] [Abstract][Full Text] [Related]
16. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
17. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
18. A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas.
Carleton C; Hoang L; Sah S; Kiyokawa T; Karamurzin YS; Talia KL; Park KJ; McCluggage WG
Am J Surg Pathol; 2016 May; 40(5):636-44. PubMed ID: 26685087
[TBL] [Abstract][Full Text] [Related]
19. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
[TBL] [Abstract][Full Text] [Related]
20. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
Laframboise S; Chapman W; McLaughlin J; Andrulis IL
Cancer J; 2000; 6(5):302-8. PubMed ID: 11079169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
